-
1
-
-
0001419666
-
-
FIP Guidelines for Dissolution Testing of Solid Oral Products. Pharm Ind. 1981; 43: 334–343.
-
(1981)
Pharm Ind
, vol.43
, pp. 334-343
-
-
-
2
-
-
6844230351
-
Dissolution Methodology
-
Leeson LJ, Carstensen JT,(Eds.). Washington, DC; APhA
-
Pernarowski M. Dissolution Methodology. In Leeson LJ, Carstensen JT,(Eds.). Dissolution Technology. Washington, DC; APhA: 1974.
-
(1974)
Dissolution Technology
-
-
Pernarowski, M.1
-
3
-
-
0017965932
-
Kritischer Vergleich von Geräten und Methoden zur Bestimmung der Auflösungsgeschwindigkeit von Tabletten
-
Krowczynski L. Kritischer Vergleich von Geräten und Methoden zur Bestimmung der Auflösungsgeschwindigkeit von Tabletten. Pharmazie. 1978; 33: 241–247.
-
(1978)
Pharmazie
, vol.33
, pp. 241-247
-
-
Krowczynski, L.1
-
4
-
-
6844256426
-
Dissolution Methology: an Overview
-
Dakkuri A Shak AC. Dissolution Methology: an Overview. Pharm Technol. 1982; 2: 41–53.
-
(1982)
Pharm Technol
, vol.2
, pp. 41-53
-
-
Dakkuri, A.1
Shak, A.C.2
-
5
-
-
0022608713
-
Advances in Dissolution Technology: Design, pros and cons
-
Lathia CD Banakar WV. Advances in Dissolution Technology: Design, pros and cons. Drug Dev Ind Pharm. 1986; 12: 71–105.
-
(1986)
Drug Dev Ind Pharm
, vol.12
, pp. 71-105
-
-
Lathia, C.D.1
Banakar, W.V.2
-
6
-
-
6844219732
-
Associations and Specifications
-
Blume H, Grundert-Remy U, Möller H,(Eds). Stuttgart: Wissenschaftliche Verlagsgesellschaft
-
Siewert M. Associations and Specifications. In Blume H, Grundert-Remy U, Möller H,(Eds). Controlled/Modified Release Products. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1991.
-
(1991)
Controlled/Modified Release Products
-
-
Siewert, M.1
-
7
-
-
0019497850
-
Effect of Sampling Probe Size on Dissolution of Tableted Drug Samples
-
Wells CE. Effect of Sampling Probe Size on Dissolution of Tableted Drug Samples. J Pharm Sci. 1981; 70: 232–233.
-
(1981)
J Pharm Sci
, vol.70
, pp. 232-233
-
-
Wells, C.E.1
-
8
-
-
0021153312
-
Optimierung und Justierung der Versuchsbedingungen von in vitro-Tests: Feste perorale Arzneizubereitungen
-
Stricker H. Optimierung und Justierung der Versuchsbedingungen von in vitro-Tests: Feste perorale Arzneizubereitungen. Acta Pharm Technol. 1984; 30: 113–125.
-
(1984)
Acta Pharm Technol
, vol.30
, pp. 113-125
-
-
Stricker, H.1
-
9
-
-
0017276562
-
In-vitro-Studien zum Auflöse- und Resorptionsverhalten oral verabreichter Arzneistoffe und die Korrelation mit der biologischen Verfügbarkeit
-
Stricker H. In-vitro-Studien zum Auflöse- und Resorptionsverhalten oral verabreichter Arzneistoffe und die Korrelation mit der biologischen Verfügbarkeit. Pharm Ind. 1976; 38: 232–234.
-
(1976)
Pharm Ind
, vol.38
, pp. 232-234
-
-
Stricker, H.1
-
10
-
-
6844219731
-
Verfügbarkeitsprufung in vitro: Forderungen, Möglichkeiten, Grenzen
-
Dibbern HW. Verfügbarkeitsprufung in vitro: Forderungen, Möglichkeiten, Grenzen. Pharm Ind. 1984; 46: 381–385.
-
(1984)
Pharm Ind
, vol.46
, pp. 381-385
-
-
Dibbern, H.W.1
-
11
-
-
0023881733
-
Simulation of physiological pH-time profile in in vitro dissolution study: Relationship between dissolution rate and bioavailability of controlled release dosage form
-
Das SK Gupta BK. Simulation of physiological pH-time profile in in vitro dissolution study: Relationship between dissolution rate and bioavailability of controlled release dosage form. Drug Dev Ind Pharm. 1988; 14: 537–544.
-
(1988)
Drug Dev Ind Pharm
, vol.14
, pp. 537-544
-
-
Das, S.K.1
Gupta, B.K.2
-
12
-
-
0007938726
-
Zur pharmazeutischen Qualität von glibenclamidhaltigen Fertigarzneimitteln
-
Blume H Ali SL Siewert M. Zur pharmazeutischen Qualität von glibenclamidhaltigen Fertigarzneimitteln. Pharm Ztg. 1984; 129: 983–989.
-
(1984)
Pharm Ztg
, vol.129
, pp. 983-989
-
-
Blume, H.1
Ali, S.L.2
Siewert, M.3
-
14
-
-
84993719124
-
Guidelines for Design and Evaluation of Oral Sustained Release Dosage Form
-
Yakuskin-1–5
-
Guidelines for Design and Evaluation of Oral Sustained Release Dosage Form. Ministry of Health and Welfare of Japan. Yakuskin-1–5; 1988.
-
(1988)
Ministry of Health and Welfare of Japan
-
-
-
15
-
-
0025147050
-
Workshop Report In Vitro and In Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms
-
Workshop Report In Vitro and In Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms. Pharm Res. 1990; 7: 975–982.
-
(1990)
Pharm Res
, vol.7
, pp. 975-982
-
-
-
17
-
-
0026657633
-
Influence of Higher Rates of Agitation on Release Patterns of Immediate-Release Drug Products
-
Shah VP Gurbarg M Noory A Dighe S Skelly JP. Influence of Higher Rates of Agitation on Release Patterns of Immediate-Release Drug Products. J Pharm Sci. 1991; 81(6):500–503.
-
(1991)
J Pharm Sci
, vol.81
, Issue.6
, pp. 500-503
-
-
Shah, V.P.1
Gurbarg, M.2
Noory, A.3
Dighe, S.4
Skelly, J.P.5
-
19
-
-
0001262837
-
Impact of Different Deaeration Methods on the USP Dissolution Apparatus Suitability Test Criteria
-
Qureshi SA McGilveray IJ. Impact of Different Deaeration Methods on the USP Dissolution Apparatus Suitability Test Criteria. Pharm Forum. 1994; 20(6): 8565–8566.
-
(1994)
Pharm Forum
, vol.20
, Issue.6
, pp. 8565-8566
-
-
Qureshi, S.A.1
McGilveray, I.J.2
-
21
-
-
84993767565
-
-
Supplement 1: Drug Release 724
-
U.S. Pharmacopeia 23, Supplement 1: Drug Release 724 2535; 1995.
-
(1995)
U.S. Pharmacopeia
, vol.23
, Issue.2535
-
-
-
22
-
-
0020400710
-
Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability
-
Langenbucher F. Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability. Pharm Ind. 1982; 44: 1166–1172.
-
(1982)
Pharm Ind
, vol.44
, pp. 1166-1172
-
-
Langenbucher, F.1
-
23
-
-
0001452477
-
Improved algorithms correlating body response with drug input
-
Langenbucher F. Improved algorithms correlating body response with drug input. Pharm Ind. 1982; 44: 1275–1278.
-
(1982)
Pharm Ind
, vol.44
, pp. 1275-1278
-
-
Langenbucher, F.1
-
24
-
-
6844244808
-
Percent absorbed time plots derived from blood level or urinary excretion data
-
Wagner JW Nelson F. Percent absorbed time plots derived from blood level or urinary excretion data. J Pharm Sci. 1963; 57: 918–928.
-
(1963)
J Pharm Sci
, vol.57
, pp. 918-928
-
-
Wagner, J.W.1
Nelson, F.2
-
25
-
-
0014297946
-
New method for calculating the intrinsic absorption rate of drug
-
Loo JCK Riegelmann S. New method for calculating the intrinsic absorption rate of drug. J Pharm Sci. 1968; 57: 918–928.
-
(1968)
J Pharm Sci
, vol.57
, pp. 918-928
-
-
Loo, J.C.K.1
Riegelmann, S.2
-
27
-
-
0021279999
-
Momenten-Analyse und in vitro/in vivo Korrelation
-
von Hattingberg HM. Momenten-Analyse und in vitro/in vivo Korrelation. Acta Pharm Technol. 1984; 30: 93–101.
-
(1984)
Acta Pharm Technol
, vol.30
, pp. 93-101
-
-
von Hattingberg, H.M.1
-
28
-
-
0027288496
-
In vitro/in vivo Correlations: Scientific Implications and Standardisation
-
Cardot JM Beyssac E. In vitro/in vivo Correlations: Scientific Implications and Standardisation. Eur J Drug Metab Pharmacokinet. 1993; 18(1):113–120.
-
(1993)
Eur J Drug Metab Pharmacokinet
, vol.18
, Issue.1
, pp. 113-120
-
-
Cardot, J.M.1
Beyssac, E.2
-
30
-
-
0027473743
-
Workshop Report: Scale-Up of Immediate Release Oral Solid Dosage Forms
-
Workshop Report: Scale-Up of Immediate Release Oral Solid Dosage Forms. Pharm Res. 1993; 10: 313–316
-
(1993)
Pharm Res
, vol.10
, pp. 313-316
-
-
-
31
-
-
10544226592
-
-
Eur J Pharm Biopharm. 1993;39(1):40–43.
-
(1993)
Eur J Pharm Biopharm
, vol.39
, Issue.1
, pp. 40-43
-
-
-
32
-
-
0027144435
-
Workshop II Report: Scale-Up of Oral Extended Release Dosage Forms
-
Workshop II Report: Scale-Up of Oral Extended Release Dosage Forms. Pharm Res. 1993; 10: 1800–1805
-
(1993)
Pharm Res
, vol.10
, pp. 1800-1805
-
-
-
33
-
-
0027291066
-
-
Eur J Pharm Biopharm. 1993;39 (4):162–167.
-
(1993)
Eur J Pharm Biopharm
, vol.39
, Issue.4
, pp. 162-167
-
-
-
35
-
-
0022892810
-
Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation
-
Maturu PK Prasad VK Worsley W Shiu GK Skelly JP. Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation. J Pharm Sci. 1986; 75: 1205–1206.
-
(1986)
J Pharm Sci
, vol.75
, pp. 1205-1206
-
-
Maturu, P.K.1
Prasad, V.K.2
Worsley, W.3
Shiu, G.K.4
Skelly, J.P.5
-
36
-
-
0023860810
-
Food-Induced Theophylline Release/Absorption Changes from Controlled-Release Formulations: A Proposed in Vitro Model
-
Wearly L Karim A Pagone F Streicher J Wickman A. Food-Induced Theophylline Release/Absorption Changes from Controlled-Release Formulations: A Proposed in Vitro Model. Drug Devl Ind Pharm. 1988; 14: 13–28.
-
(1988)
Drug Devl Ind Pharm
, vol.14
, pp. 13-28
-
-
Wearly, L.1
Karim, A.2
Pagone, F.3
Streicher, J.4
Wickman, A.5
-
38
-
-
0025201504
-
Theophylline-Controlled Release Preparations and Fatty Food: An in vitro Study Using the Rotating Dialysis Cell
-
El-Arini K Shiu GK Skelly JP. Theophylline-Controlled Release Preparations and Fatty Food: An in vitro Study Using the Rotating Dialysis Cell. Pharm Res. 1990; 7: 1134–1140.
-
(1990)
Pharm Res
, vol.7
, pp. 1134-1140
-
-
El-Arini, K.1
Shiu, G.K.2
Skelly, J.P.3
-
39
-
-
0023038127
-
Drug dissolution studies in milk using the automated flow injection serial dynamic dialysis technique
-
Macheras P Koupparis M Tsaprounis C. Drug dissolution studies in milk using the automated flow injection serial dynamic dialysis technique. Int J Pharm. 1986; 33: 125–136.
-
(1986)
Int J Pharm
, vol.33
, pp. 125-136
-
-
Macheras, P.1
Koupparis, M.2
Tsaprounis, C.3
-
40
-
-
0025041478
-
Eine neues in vitro-Modell zur Erkennung von Wechselwirkungen zwischen Retardarzneimitteln zur oralen Applikation und Nahrungsmitteln
-
Junginger HE Verhoeven J Peschier LJC. Eine neues in vitro-Modell zur Erkennung von Wechselwirkungen zwischen Retardarzneimitteln zur oralen Applikation und Nahrungsmitteln. Pharm Ztg Wiss. 1990; 2: 53–58.
-
(1990)
Pharm Ztg Wiss
, vol.2
, pp. 53-58
-
-
Junginger, H.E.1
Verhoeven, J.2
Peschier, L.J.C.3
-
42
-
-
6844224166
-
In vitro-Dissolution Testing of Oral Controlled Release Products
-
Gundert-Remy U Möller H. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft
-
Siewert M. In vitro-Dissolution Testing of Oral Controlled Release Products. In: Gundert-Remy U Möller H. Oral Controlled Release Products Therapeutic and Biopharmaceutic Assessment. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft: 139–154.
-
Oral Controlled Release Products Therapeutic and Biopharmaceutic Assessment
, pp. 139-154
-
-
Siewert, M.1
|